930786-44-0

Upstream product

• 89598-96-9 (3-bromophenyl)boronic acid 
• 103264-70-6 2-(3-hydroxy-4-methylphenyl)acetonitrile 
• 143-33-9 sodium cyanide 

Downstream Products

• 930786-45-1 [3-(3-Bromo-phenoxy)-4-chloro-phenyl]-acetic acid ethyl ester 
• 1361393-69-2 C₁₈H₁₀BrCl₂N₃O 

Relevant academic research and scientific papers

Non-nucleoside reverse transcriptase inhibitors

The present invention provides compounds of formula I where R1 to R4 are as defined herein which are useful for treating or preventing an human immunodeficiency virus (HIV) infection, or treating AIDS or ARC. The invention further provides for methods of treating or preventing HIV infection with compounds according to formula I and compositions containing the same. The invention still further provides process for the preparation of compounds of formula I wherein R4 is A1 and X1 is NH or O.

Non-nucleoside reverse transcriptase inhibitors

This invention relates to novel heterocyclic compounds of formula I wherein R1—R4, X1 and X2 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modula

Non-nucleoside reverse transcriptase inhibitors

This invention relates to novel pyridazinone derivatives of formula I wherein R1-R4, R7, R8 and X1 are as defined in the summary and pharmaceutically acceptable salts and solvates thereof, methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I, pharmaceutical compositions containing of formula I admixed with at least one solvent, carrier or excipient and processes to prepare compounds of formula I. The compounds are useful for treating disorders in which HIV and genetically related viruses are implicated